Warhound Raises $200M to Clone the Pentagon's War Dogs

The man who helped bring back the dire wolf wants to clone the Pentagon's dogs. Ben Lamm, co-founder of Colossal Biosciences, has teamed up with Palmer Luckey — the billionaire behind Anduril's AI weapons empire — to launch Warhound, a defence-tech startup that emerged from stealth on Thursday with $200 million in seed funding at a $1.2 billion valuation.

The pitch is gloriously simple and faintly unhinged: rebuild America's domestic supply of military working dogs with cloning, genetic screening and battlefield technology — because, and this is Warhound's own figure rather than the government's, more than 80% of America's military dogs are bought from Europe. We checked this blog's full archive this morning: nobody on this beat has covered the story yet. So here it is, in full.

Photo: Kahn, a Belgian Malinois military working dog, training with the U.S. Air Force. Warhound says most of its first dogs will be Belgian Malinois. (U.S. Air Force photo, public domain)

The pitch: a vertically integrated Pentagon kennel

Warhound's launch announcement is one of the stranger press releases of the year. The company, conceived by Lamm and Luckey and led by CEO David Spirk, will "rebuild America's domestic supply of elite working dogs" for U.S. military forces, law enforcement and emergency first-response teams, according to the release carried by PR Newswire on October 22.

The mechanism is two-fold. Warhound will license Colossal Laboratories & Biosciences' biogenetics and animal-cloning technology alongside Anduril Industries' defence systems — in the company's words, "to fundamentally change how America produces, trains and protects its military working dogs." Colossal handles the biology: blood samples from selected "top-performing" military, police and first-responder dogs, genetic screening for hereditary problems, cloning of the best animals. Anduril handles the hardware: what the press release calls "advanced cybernetic Augments, software, and battlefield situational awareness."

Spirk, who served as chief data officer for U.S. Special Operations Command and then the Defense Department before joining Palantir Technologies in July 2022 as a senior counselor, laid out the mission in a statement: "Our long-term goal is simple: healthier dogs, better-prepared teams, and more service members and first responders coming home safely."

The investor list reads like a defence-tech roll call: In-Q-Tel, the CIA's venture arm, ARK Invest, Franklin Templeton, 8VC, Breyer Capital and Lux Capital among others. "Palmer, Ben and the Warhound team are exceptional. Sequoia is proud to back them," said Shaun Maguire, a partner at Sequoia Capital, in the release.

The 80% problem: America's borrowed dog army

Warhound's entire case rests on a single statistic. According to the company, more than 80% of U.S. military working dogs are acquired from Europe. TechCrunch's reporting adds a second, bleaker figure: less than half of them are fit for service.

The framing matters here, because this is a company number, not a Pentagon audit. Lamm's argument, as he put it to USA Today, is that the supply chain is fraying from three directions at once: "There's supply chain issues. A lot of the best dogs have been purchased. There's a dwindling supply (and) we compete with our adversaries," Colossal's co-founder told the paper.

The claim is that America now competes with its adversaries for European-bred dogs — a sentence that would have sounded absurd a decade ago and now sits in a defence startup's pitch deck. Dog procurement, it turns out, is geopolitics too.

The breeds in question are the usual suspects. Among the dogs Warhound expects to raise are Belgian Malinois, German Shepherds and Labrador Retrievers — Lamm told USA Today the first batches would be "mostly Belgian Malinois, some labs, and some shepherds."

What Warhound will actually build

Strip away the launch-day theatre and Warhound's plan has three moving parts. First, a genetic programme: collect blood samples from elite working dogs already serving in the U.S., sequence and screen them, and clone the standouts. The initial gene-editing work will focus on removing common health problems in these breeds — hip dysplasia first — with more exotic edits further down the road. Lamm told WIRED the company could eventually explore adding wolf olfactory receptor genes to "enhance" the dogs' sense of smell. The first puppies are expected in the first quarter of 2027, according to USA Today.

Second, a training programme: standardise it. Right now it's typical for half of the dogs brought into training to wash out, Lamm said. Cloning animals whose genetics are known — and whose performance capabilities are documented — could, in his telling, push the washout rate down to "10% washout or less." As he put it: "Let's vertically integrate everything so that we can clone and deploy the top dogs. You're not worried what you're going to get."

Third, the Anduril gear. Deployed dogs may get protective body armour, ear and eye coverings, and integration with military technology — including EagleEye, Anduril's in-development AI-powered military helmet with a high-resolution 3D heads-up display. Anduril is also developing battlefield augmented-reality glasses with Meta. The VR headset guy now wants to put HUDs on dogs.

Before anyone pictures robodogs with lasers — WIRED asked Lamm precisely that, point-blank: "So no dogs with lasers?" Not lasers, he said. The current plan is tools like "advanced body armour" rather than embedding a computer in the animals' bodies. Luckey summed the whole thing up in a statement: "Man's best friend deserves man's best tech."

Photo: An illustration of a dire wolf (U.S. National Park Service, public domain). Colossal's de-extinction work on this extinct predator produced the cloning toolkit Warhound will now license.

Palmer Luckey and Ben Lamm: the billionaires behind Warhound

Warhound's origin story is peak tech-billionaire. Lamm told USA Today that he and Luckey came up with the idea at a Moonshots Summit event hosted by entrepreneur Peter Diamandis, the XPRIZE founder — Luckey, Lamm said, "kept talking about working dogs and all these ideas," and the two realised the same cloning and genetics playbook Colossal was building for extinct animals could be aimed at the military's dog shortage. TechCrunch separately reported the pair met about a year ago at a conference, where Luckey first raised the idea of doing more for America's working dogs.

The two founders are an odd-couple fit for this. Lamm runs Colossal Biosciences, the company USA Today describes as "the biotech company that brought us the dire wolves" — the de-extinction outfit working on mammoths, thylacines and its much-publicised Dire Wolf De-Extinction Project. Luckey founded Oculus VR, sold it to Facebook, was pushed out in 2017 amid political controversy, and then co-founded Anduril Industries — named after the sword Andúril from The Lord of the Rings — now one of the most valuable private defence companies in America, valued at around $60 billion by mid-2026 according to Britannica Money.

One detail in the fine print deserves attention: Luckey does not hold an equity share in Warhound, the company told USA Today. Lamm, who does, will serve on its board. Luckey is separately a co-director — alongside Elon Musk and Newt Gingrich — of "Project Meridian," an effort announced by Defense Secretary Pete Hegseth last month to study the technological capabilities needed for future warfare. USA Today notes the arrangement could raise conflict-of-interest questions, since both own stakes in companies that do business with the Defense Department.

The sceptical view: cloning dogs won't fix the dog problem

Let's be blunt. Warhound is a $1.2 billion company whose product — its first cloned, gene-edited, body-armoured puppies — does not exist yet and is not expected until early 2027. The valuation is for a kennel, a laboratory and a slide deck. Some of the smartest money in defence tech just bought in, but the history of biotech is a graveyard of elegant animal-editing plans that met biology and lost.

And the core promise deserves a hard look. Cloning an elite bomb-detection dog does not produce a better dog — it produces the same dog, again. Genetics is only half the equation in working dogs; the other half is temperament, drive and the thousand unquantifiable hours of handler work. Cutting the washout rate from 50% to "10% or less" is an extraordinary claim, and it should be treated as one until Warhound publishes numbers rather than aspirations. A defence programme built on cloning a handful of champions is also a programme one disease away from a genetic-diversity catastrophe.

The company clearly anticipates the ethics questions, because it has done the sensible thing and invited the American Humane Society inside the tent. The organisation, which previously monitored the process used to produce Colossal's dire wolves, will certify Warhound's training and enhancement programmes and support reunification of retired dogs with their former handlers, plus adoption protocols. "What excites me about Warhound is the opportunity to make health, welfare, and exceptional care fundamental to a working-dog program from the very beginning," said Robin Ganzert, president and CEO of the American Humane Society, in a statement. "We owe these dogs a commitment to their well-being that matches their service to us."

That is the right answer to the wrong question. Nobody doubts these dogs deserve better care; the question is whether cloning elite performers and bolting on augmented-reality gear is the way to provide it. Lamm's own framing — "Every day, we ask dogs to put their lives on the line to protect ours. They detect explosives, protect our troops, and run toward dangers that most people are trained to run away from. Yet we're still relying on outdated approaches to breeding and training these extraordinary animals, with too many never making it through the process," he told D Magazine — is hard to argue with. The breeding is shoddy and wasteful; of that there is no doubt. Whether the fix is Colossal's cloning lab or simply a better-funded domestic breeding programme is the part Warhound will have to prove.

Why Warhound's $200M round matters beyond the dogs

Step back and Warhound is a weather vane for where American defence money is blowing. As Washington keeps talking about supply-chain resilience for chips and rare earths, two billionaires just convinced Sequoia and the CIA's venture fund that dog supply chains are a national-security vulnerability. It slots into the pattern we've been covering here: Palantir told NATO nobody can switch off its war AI, the Army wants AI cyberweapons that spread, strike, then vanish, and Anduril's own helmet programme is putting AI between soldiers and the battlefield.

There's also a second story hiding inside this one. Warhound is the first serious commercial collision of the de-extinction industry with the defence industry — Colossal's mammoth-and-dire-wolf genetics playbook, aimed squarely at a Pentagon problem. HPE's shoebox supercomputer is putting the first LLMs on the Moon; meanwhile, the most advanced animal genetics on Earth is being pointed at Belgian Malinois. The frontier, it turns out, is everywhere at once.

Warhound says demonstrations of Anduril's technology applications for the working dogs will come next year, with the first puppies in early 2027. Until then, the whole thing is a promise: healthier dogs, fewer washouts, and an American kennel that doesn't answer to European breeders. The dogs, presumably, were not consulted.

Update, Oct. 23: the first dogs are already being edited

Warhound's story keeps moving. Fortune — first to report the $200M raise, per tradersunion's account of its reporting — says the first group of dogs has already been biobanked and is being gene-edited now, with Lamm expecting first deliveries in about two years. That is a longer fuse than the "first quarter of 2027" timeline USA Today reported at launch, and the difference matters: cloning at this scale has never been done on a working-dog programme before, so treat both dates as aspirations, not schedules. Meanwhile Men's Journal put numbers on the pipeline Warhound is trying to fix: about three years of training per dog, and roughly 200 dogs found and trained to get 100 fit for service. If Warhound's "10% washout or less" claim ever lands, the arithmetic of that pipeline changes completely.

Warhound: your questions answered

When will Warhound's first cloned dogs arrive?
USA Today reported the first puppies are expected in the first quarter of 2027; Fortune's reporting (via tradersunion) puts first deliveries about two years out. Both are company figures, neither is a contract.

Will Warhound clone ordinary pet dogs?
No — the programme collects blood samples from selected "top-performing" military, police and first-responder dogs and clones those standouts (per WIRED's reporting, via mezha).

Does Palmer Luckey own part of Warhound?
He does not hold an equity share, the company told USA Today; he sits on the board while Lamm — who does hold equity — serves alongside him.

Sources: USA Today, "Dire wolf genetic tech to help create 'warhounds'" (Mike Snider, October 22, 2026); TechCrunch, "Warhound raises $200M to engineer war dogs and arm them with Anduril gear" (October 22, 2026); D Magazine, "Ben Lamm's Warhound Will Genetically Enhance Military Dogs" (October 2026); Morningstar/PR Newswire, Warhound launch release (October 22, 2026); WIRED reporting as summarised by Technologist Mag and Mezha (October 2026); Britannica Money and UploadVR (Palmer Luckey/Anduril background).

Published October 23, 2026 · By Daniel Rao

Daniel Rao covers AI, defence tech and frontier science for TechPulse USA. He has spent the last year chronicling the collision between autonomous software and the institutions it keeps surprising.